title: TAVI and concomitant procedures: from PCI to LAA closure.
abstract: In high-risk patients with aortic stenosis and associated cardiac comorbidities (such as coronary artery disease, atrial fibrillation or combined valve disease), transcatheter interventions offer a unique opportunity to mitigate these individuals' cardiovascular risk, either by staging the interventions, or by performing simultaneous procedures in a single session. The decision on which approach (staged vs. single session) to choose for an individual patient depends on clinical, anatomical and patient-related factors. While a staged approach may represent a preferable strategy in selected patients, concomitant treatment of combined cardiac diseases represents an appealing option in a majority of patients.
authors.affiliation: Valve Clinic, University Heart Center, University Hospital Zürich, Zürich, Switzerland.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Taramasso
authors.forename: Francesco
authors.initials: F
authors.lastname: Maisano
authors.forename: Fabian
authors.initials: F
authors.lastname: Nietlispach
mesh_terms: D000208:Acute Disease; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage; D001021:Aortic Valve / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D020517:Atrial Appendage / Q000000981:diagnostic imaging / Q000503:physiopathology; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D001705:Bioprosthesis; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D015897:Comorbidity; D018618:Echocardiography, Doppler, Color; D017548:Echocardiography, Transesophageal; D005260:Female; D006333:Heart Failure / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D018579:Patient Selection; D062645:Percutaneous Coronary Intervention; D011474:Prosthesis Design; D011475:Prosthesis Failure; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants